Impulsivity in cocaine users compared to matched controls: Effects of sex and preferred route of cocaine use.


Journal

Drug and alcohol dependence
ISSN: 1879-0046
Titre abrégé: Drug Alcohol Depend
Pays: Ireland
ID NLM: 7513587

Informations de publication

Date de publication:
01 09 2021
Historique:
received: 24 02 2021
revised: 26 04 2021
accepted: 01 05 2021
pubmed: 12 7 2021
medline: 29 9 2021
entrez: 11 7 2021
Statut: ppublish

Résumé

Impulsivity has been identified as playing a role in cocaine use. The purpose of this study was to explore self-report measures of impulsivity in large groups of male and female cocaine users and matched controls and to determine if differences in impulsivity measures within a group of cocaine users related to self-reported money spent on cocaine and route of cocaine use. Eight self-report impulsivity measures yielding 34 subscales were obtained in 230 cocaine users (180 M, 50 F) and a matched group of 119 healthy controls (89 M, 30 F). Correlational analysis of the questionnaires revealed 2 factors: Impulsive Action (Factor 1) consisting of many traditional impulsivity measures and Thrill-seeking (Factor 2) consisting of delay discounting, sensation and thrill seeking. Sex influenced within group comparisons. Impulsive Action scores did not vary as a function of sex within either group. But, male controls and male cocaine users had greater Thrill-seeking scores than females within the same group. Sex also influenced between group comparisons. Male cocaine users had greater Impulsive Action scores while female cocaine users had greater Thrill-seeking scores than their sex-matched controls. Among cocaine users, individuals who preferred insufflating ("snorting") cocaine had greater Thrill-seeking scores and lower Impulsive Action scores than individuals who preferred smoking cocaine. Individuals who insufflate cocaine also spent less money on cocaine. Greater Impulsive Action scores in males and Thrill-seeking scores in females were associated with cocaine use relative to controls.

Sections du résumé

BACKGROUND
Impulsivity has been identified as playing a role in cocaine use. The purpose of this study was to explore self-report measures of impulsivity in large groups of male and female cocaine users and matched controls and to determine if differences in impulsivity measures within a group of cocaine users related to self-reported money spent on cocaine and route of cocaine use.
METHODS
Eight self-report impulsivity measures yielding 34 subscales were obtained in 230 cocaine users (180 M, 50 F) and a matched group of 119 healthy controls (89 M, 30 F). Correlational analysis of the questionnaires revealed 2 factors: Impulsive Action (Factor 1) consisting of many traditional impulsivity measures and Thrill-seeking (Factor 2) consisting of delay discounting, sensation and thrill seeking.
RESULTS
Sex influenced within group comparisons. Impulsive Action scores did not vary as a function of sex within either group. But, male controls and male cocaine users had greater Thrill-seeking scores than females within the same group. Sex also influenced between group comparisons. Male cocaine users had greater Impulsive Action scores while female cocaine users had greater Thrill-seeking scores than their sex-matched controls. Among cocaine users, individuals who preferred insufflating ("snorting") cocaine had greater Thrill-seeking scores and lower Impulsive Action scores than individuals who preferred smoking cocaine. Individuals who insufflate cocaine also spent less money on cocaine.
CONCLUSIONS
Greater Impulsive Action scores in males and Thrill-seeking scores in females were associated with cocaine use relative to controls.

Identifiants

pubmed: 34246916
pii: S0376-8716(21)00335-5
doi: 10.1016/j.drugalcdep.2021.108840
pmc: PMC8355072
mid: NIHMS1720924
pii:
doi:

Substances chimiques

Cocaine I5Y540LHVR

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

108840

Subventions

Organisme : NIDA NIH HHS
ID : R01 DA035846
Pays : United States
Organisme : NIDA NIH HHS
ID : T32 DA007294
Pays : United States

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Références

Assessment. 2002 Sep;9(3):254-60
pubmed: 12216782
J Exp Psychol Gen. 1999 Mar;128(1):78-87
pubmed: 10100392
Brain Struct Funct. 2017 Jan;222(1):215-227
pubmed: 27095357
Behav Neurosci. 2007 Jun;121(3):543-9
pubmed: 17592945
Exp Clin Psychopharmacol. 2013 Dec;21(6):490-8
pubmed: 24364538
Exp Clin Psychopharmacol. 2011 Jun;19(3):243-8
pubmed: 21517195
Exp Clin Psychopharmacol. 2003 Feb;11(1):18-25
pubmed: 12622340
Behav Pharmacol. 2009 Sep;20(5-6):390-9
pubmed: 19724194
Neurocase. 2008;14(1):93-121
pubmed: 18569735
J Psychopharmacol. 2015 Jan;29(1):50-6
pubmed: 25424624
Appetite. 2012 Oct;59(2):289-97
pubmed: 22634199
Behav Neurosci. 2010 Aug;124(4):470-7
pubmed: 20695646
J Psychiatr Res. 2012 Aug;46(8):994-1001
pubmed: 22626529
Addict Behav. 2015 Feb;41:1-6
pubmed: 25280245
Drug Alcohol Depend. 2013 Nov 1;133(1):61-70
pubmed: 23806872
Am J Drug Alcohol Abuse. 2007;33(2):191-206
pubmed: 17497542
Exp Clin Psychopharmacol. 2020 Dec;28(6):724-738
pubmed: 31886701
Psychol Sci. 2015 Jun;26(6):709-23
pubmed: 25870404
Addict Behav. 2018 Jan;76:52-60
pubmed: 28755613
Neurosci Biobehav Rev. 2004 May;28(3):343-51
pubmed: 15225976
Exp Clin Psychopharmacol. 2016 Feb;24(1):30-7
pubmed: 26691847
Front Psychiatry. 2016 Mar 10;7:34
pubmed: 27014100
Psychol Bull. 2011 Jan;137(1):97-130
pubmed: 21219058
Drug Alcohol Depend. 2008 Aug 1;96(3):256-62
pubmed: 18468814
Pharmacol Biochem Behav. 2008 Sep;90(3):331-8
pubmed: 18445506
Addict Behav. 2006 Jul;31(7):1290-4
pubmed: 16236455
Drug Alcohol Depend. 2013 Jun 1;130(1-3):101-8
pubmed: 23182839
J Addict Med. 2011 Mar;5(1):65-73
pubmed: 21769049
Biol Psychiatry. 2002 Jun 15;51(12):988-94
pubmed: 12062883
PLoS One. 2015 May 27;10(5):e0128641
pubmed: 26017273
Subst Abus. 2013;34(1):4-12
pubmed: 23327499
Addict Biol. 2009 Jan;14(1):22-31
pubmed: 18855805
BMJ Open. 2015 Dec 18;5(12):e009445
pubmed: 26685032
Psychol Assess. 2011 Sep;23(3):725-38
pubmed: 21480721
Psychiatr Clin North Am. 2010 Jun;33(2):339-55
pubmed: 20385341
Neuroimage Clin. 2017 Mar 31;14:750-759
pubmed: 28413777
Drug Alcohol Depend. 2013 Sep 1;132(1-2):195-201
pubmed: 23497788
Psychopharmacology (Berl). 2011 Aug;216(3):305-21
pubmed: 21373791
Drug Alcohol Depend. 2016 Jun 01;163:141-52
pubmed: 27114203
J Subst Abuse Treat. 2001 Dec;21(4):193-8
pubmed: 11777668
Trends Cogn Sci. 2012 Jan;16(1):81-91
pubmed: 22155014
Philos Trans R Soc Lond B Biol Sci. 2019 Feb 18;374(1766):20180129
pubmed: 30966924
Arch Gen Psychiatry. 2010 Jun;67(6):632-44
pubmed: 20530013
Drug Alcohol Depend. 2011 May 1;115(1-2):120-30
pubmed: 21145178
J Consult Clin Psychol. 1978 Feb;46(1):139-49
pubmed: 627648
Addiction. 2004 Apr;99(4):461-71
pubmed: 15049746
Drug Alcohol Depend. 2009 Oct 1;104(3):197-203
pubmed: 19570621
J Clin Psychol. 1995 Nov;51(6):768-74
pubmed: 8778124
Psychopharmacology (Berl). 1999 Oct;146(4):348-61
pubmed: 10550486
Subst Use Misuse. 2018 May 12;53(6):972-979
pubmed: 29116870
Addict Behav. 2008 Feb;33(2):252-65
pubmed: 17913380
Psychol Med. 2015 Oct;45(14):3097-110
pubmed: 26081043

Auteurs

Richard W Foltin (RW)

Division on Substance Use Disorders, New York State Psychiatric Institute and Department of Psychiatry, Columbia University Vagelos College of Physicians and Surgeons and Columbia University Irving Medical Center, 1051 Riverside Drive, New York, NY, 10032, USA. Electronic address: rwf2@cumc.columbia.edu.

Rachel Luba (R)

Division on Substance Use Disorders, New York State Psychiatric Institute and Department of Psychiatry, Columbia University Vagelos College of Physicians and Surgeons and Columbia University Irving Medical Center, 1051 Riverside Drive, New York, NY, 10032, USA.

Yuan Chen (Y)

Division on Biostatistics, Mailman School of Public Health, Columbia University, 722 W 168th St, New York, NY, 10032, USA.

Yuanjia Wang (Y)

Division on Biostatistics, Mailman School of Public Health, Columbia University, 722 W 168th St, New York, NY, 10032, USA.

Suzette M Evans (SM)

Division on Substance Use Disorders, New York State Psychiatric Institute and Department of Psychiatry, Columbia University Vagelos College of Physicians and Surgeons and Columbia University Irving Medical Center, 1051 Riverside Drive, New York, NY, 10032, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH